{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:48:34Z","timestamp":1740152914991,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Existing evidence suggests a relation between cardiovascular dysfunction and diminished ovarian reserve. While it is known that pre-existent cardiovascular dysfunction is also associated with the development of preeclampsia (PE) during pregnancy, we hypothesize that signs of diminished ovarian reserve may occur more frequently among women with a history of hypertensive disorders of pregnancy (HDP). The aim of our study was therefore to analyse if women with a history of HDP show signs of diminished ovarian reserve, represented by lower anti-Mullarian hormone (AMH) levels, compared to controls. For this retrospective observational case control study, patients included women with a history of HDP, whereas controls constituted of women with a history of an uncomplicated pregnancy. The study was conducted in a tertiary referral centre in which all women underwent a one-time cardiovascular and metabolic assessment. Ovarian reserve and markers of cardiovascular function were evaluated, adjusted for age and body mass index (BMI) using linear regression analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>163 patients and 81 controls were included over a time span of 3 years. No signs of diminished ovarian reserve i.e. lower AMH level were observed in the patient group versus controls. A subgroup analysis even showed higher AMH levels in late onset HDP as compared to controls (2.8 vs. 2.0\u00a0\u00b5g\/L, <jats:italic>p<\/jats:italic> = 0.025). As expected, cardiovascular function markers were significantly less favourable in the patient group compared to controls; higher levels of systolic blood pressure (BP) (5%), diastolic BP (4%), triglycerides (29%), glucose (4%) and insulin levels (81%) (all <jats:italic>p<\/jats:italic> &lt; 0.05), whereas high density lipid (HDL) cholesterol was 12% lower (NS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Despite unfavourable cardiovascular risk profile, the present study does not substantiate the hypothesis that women with HDP show accelerated ovarian ageing as compared to healthy parous controls. Although HDP patients should be warned about their cardiovascular health, they shouldn\u2019t be concerned about unfavourable ovarian reserve status.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01333-9","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:02:12Z","timestamp":1704531732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["No evidence for a diminished ovarian reserve among patients with hypertensive disorders of pregnancy: a case control study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2898-9178","authenticated-orcid":false,"given":"Bo E.","family":"van Bree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Jorissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e A.P.M.","family":"Pattinaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.P.","family":"Bons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.A.","family":"Spaanderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron J.T.","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"11","key":"1333_CR1","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/humrep\/del155","volume":"21","author":"GH Woldringh","year":"2006","unstructured":"Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF\/ICSI pregnancies. Hum Reprod. 2006;21(11):2948\u201354.","journal-title":"Hum Reprod"},{"issue":"9461","key":"1333_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785\u201399.","journal-title":"Lancet"},{"issue":"9741","key":"1333_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631\u201344.","journal-title":"Lancet"},{"issue":"2","key":"1333_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1210\/jc.2013-2902","volume":"99","author":"F Yarde","year":"2014","unstructured":"Yarde F, Maas AH, Franx A, Eijkemans MJ, Drost JT, van Rijn BB, et al. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. J Clin Endocrinol Metab. 2014;99(2):579\u201386.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1333_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.fertnstert.2013.05.009","volume":"100","author":"F Yarde","year":"2013","unstructured":"Yarde F, Voorhuis M, D\u00f3lleman M, Knauff EA, Eijkemans MJ, Broekmans FJ. Antim\u00fcllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study. Fertil Steril. 2013;100(3):831\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"1333_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.116.025968","volume":"135","author":"AC de Kat","year":"2017","unstructured":"de Kat AC, Verschuren WM, Eijkemans MJ, Broekmans FJ, van der Schouw YT. Anti-M\u00fcllerian hormone trajectories are Associated with Cardiovascular Disease in women: results from the Doetinchem Cohort Study. Circulation. 2017;135(6):556\u201365.","journal-title":"Circulation"},{"issue":"3","key":"1333_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/ajo.12183","volume":"54","author":"AW Shand","year":"2014","unstructured":"Shand AW, Whitton K, Pasfield A, Nassar N, McShane M, Han X, et al. Evaluation of anti-mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2014;54(3):244\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"1333_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/09513590.2015.1116065","volume":"32","author":"FF Verit","year":"2016","unstructured":"Verit FF, Akyol H, Sakar MN. Low antimullerian hormone levels may be associated with cardiovascular risk markers in women with diminished ovarian reserve. Gynecol Endocrinol. 2016;32(4):302\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1333_CR9","doi-asserted-by":"publisher","first-page":"648287","DOI":"10.3389\/fendo.2021.648287","volume":"12","author":"S Han","year":"2021","unstructured":"Han S, Zhai Y, Guo Q, Qin Y, Liu P. Maternal and neonatal Complications in patients with diminished Ovarian Reserve in In-Vitro Fertilization\/Intracytoplasmic sperm injection cycles. Front Endocrinol. 2021;12:648287.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1333_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2023.01.029","volume":"119","author":"H Ganer Herman","year":"2023","unstructured":"Ganer Herman H, Volodarsky-Perel A, Ton Nu TN, et al. Diminished ovarian reserve is a risk factor for preeclampsia and placental malperfusion lesions. Fertil Steril. 2023;119(5):794\u2013801.","journal-title":"Fertil Steril"},{"issue":"6","key":"1333_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/humupd\/dmab018","volume":"27","author":"A Busnelli","year":"2021","unstructured":"Busnelli A, Somigliana E, Cirillo F, Levi-Setti PE. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis. Hum Reprod Update. 2021;27(6):973\u201388.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1333_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.fertnstert.2020.02.112","volume":"114","author":"S Hu","year":"2020","unstructured":"Hu S, Xu B, Jin L. Perinatal outcome in young patients with diminished ovarian reserve undergoing assisted reproductive technology. Fertil Steril. 2020;114(1):118\u2013124e1.","journal-title":"Fertil Steril"},{"issue":"5","key":"1333_CR13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/AOG.0b013e31828ea3b5","volume":"121","author":"BB van Rijn","year":"2013","unstructured":"van Rijn BB, Nijdam ME, Bruinse HW, Roest M, Uiterwaal CS, Grobbee DE, et al. Cardiovascular Disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol. 2013;121(5):1040\u20138.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1333_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1067\/mob.2003.253","volume":"188","author":"IM Bernstein","year":"2003","unstructured":"Bernstein IM, Shapiro RE, Whitsel A, Schonberg AL. Relationship of plasma volume to sympathetic tone in nulliparous women. Am J Obstet Gynecol. 2003;188(4):938\u201342.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1333_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ng.387","volume":"41","author":"L Stolk","year":"2009","unstructured":"Stolk L, Zhai G, van Meurs JBJ, Verbiest MMPJ, Visser JA, Estrada K, et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet. 2009;41(6):645\u20137.","journal-title":"Nat Genet"},{"issue":"7872","key":"1333_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","volume":"596","author":"KS Ruth","year":"2021","unstructured":"Ruth KS, Day FR, Hussain J, Mart\u00ednez-Marchal A, Aiken CE, Azad A, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. 2021;596(7872):393\u20137.","journal-title":"Nature"},{"issue":"3","key":"1333_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.rbmo.2022.02.027","volume":"45","author":"JSE Laven","year":"2022","unstructured":"Laven JSE. Early menopause results from instead of causes premature general ageing. Reprod Biomed Online. 2022;45(3):421\u20134.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1333_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0020-7292(92)90257-J","volume":"39","author":"JA Collins","year":"1992","unstructured":"Collins JA, Crosignani PG. Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Gynaecol Obstet. 1992;39(4):267\u201375.","journal-title":"Int J Gynaecol Obstet"},{"issue":"9327","key":"1333_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(02)09417-5","volume":"360","author":"JL Evers","year":"2002","unstructured":"Evers JL. Female subfertility. Lancet. 2002;360(9327):151\u20139.","journal-title":"Lancet"},{"issue":"1","key":"1333_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00404-016-4193-8","volume":"295","author":"P Bhide","year":"2017","unstructured":"Bhide P, V\u00e5rtun \u00c5, Aune B, Flo K, Basnet P, Acharya G. Ovarian reserve in women with a previous history of severe pre-eclampsia. Arch Gynecol Obstet. 2017;295(1):233\u20138.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"1333_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.fertnstert.2009.01.092","volume":"93","author":"J van Disseldorp","year":"2010","unstructured":"van Disseldorp J, Eijkemans R, Fauser B, Broekmans F. Hypertensive pregnancy Complications in poor and normal responders after in vitro fertilization. Fertil Steril. 2010;93(2):652\u20137.","journal-title":"Fertil Steril"},{"issue":"5","key":"1333_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2023.01.029","volume":"119","author":"H Ganer Herman","year":"2023","unstructured":"Ganer Herman H, Volodarsky-Perel A, Ton Nu TN, Machado-Gedeon A, Cui Y, Shaul J, et al. Diminished ovarian reserve is a risk factor for preeclampsia and placental malperfusion lesions. Fertil Steril. 2023;119(5):794\u2013801.","journal-title":"Fertil Steril"},{"issue":"8","key":"1333_CR23","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can Anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and Meta-analysis of extracted data. J Clin Endocrinol Metabolism. 2013;98(8):3332\u201340.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1333_CR24","first-page":"24","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Disorders of Pregnancy Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertensive Disorders of Pregnancy Hypertension"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01333-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01333-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01333-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T21:16:01Z","timestamp":1704575761000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01333-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01333-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"type":"electronic","value":"1757-2215"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written informed consent, approval was obtained from the ethical committee of MUMC+ (MEC 13-2-001.10\/pl).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}